We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Widecells Group Plc | LSE:WDC | London | Ordinary Share | GB00BD060S65 | ORD GBP0.0025 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.285 | 0.28 | 0.29 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2022 to Dec 2024
TIDMICON
RNS Number : 8807T
Iconic Labs PLC
22 March 2023
Iconic Labs PLC
("Iconic" or the "Company")
EHGOSF Subscribes for a GBP150,000 Fifth Tranche Under GBP 3million Financing Facility
Iconic Labs PLC (LSE: ICON) announces that. the European High Growth Opportunities Securitization Fund ("EHGOSF") has subscribed for a GBP150,000 fifth tranche of convertible notes under the GBP3million financing facility (the "Facility") that was entered into on 28 September 2022. This subscription takes the total subscribed under the Facility to GBP850,000.
In exchange, Iconic will issue 150 convertible notes to EHGOSF along with 1,250,000,000 warrants with an exercise price of GBP0.00006.
The funds under this fifth tranche shall be used to meet Iconic's obligations under the CVA and for operational purposes.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCPPUQCWUPWGGP
(END) Dow Jones Newswires
March 22, 2023 07:48 ET (11:48 GMT)
1 Year Widecells Chart |
1 Month Widecells Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
